GlucoTrack, Inc. (GCTK)
NASDAQ: GCTK · Real-Time Price · USD
5.73
-0.14 (-2.39%)
At close: Dec 12, 2025, 4:00 PM EST
5.65
-0.08 (-1.40%)
After-hours: Dec 12, 2025, 7:44 PM EST
GlucoTrack Market Cap
GlucoTrack has a market cap or net worth of $5.22 million as of December 12, 2025. Its market cap has increased by 43.66% in one year.
Market Cap
5.22M
Enterprise Value
647.24K
1-Year Change
43.66%
Ranking
Category
Stock Price
$5.73
Market Cap Chart
Since April 25, 2013, GlucoTrack's market cap has decreased from $34.13M to $5.22M, a decrease of -84.71%. That is a compound annual growth rate of -13.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 5.22M | -12.84% |
| Dec 31, 2024 | 5.99M | 9.59% |
| Dec 29, 2023 | 5.46M | -74.96% |
| Dec 30, 2022 | 21.82M | -66.12% |
| Dec 31, 2021 | 64.40M | -9.57% |
| Dec 31, 2020 | 71.22M | -26.72% |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |